Following the 2010 revision of international guidelines redefining the cut-offs for estrogen and progesterone receptor positivity in breast cancer,18 the Swedish Breast Cancer Group (SweBCG) retained the ≥ 10% threshold. This evidence concerns the gene PGR and breast cancer.